1 | parto system darman co | | | | | | | 3 | 0.30% |
2 | empowered equal and inclusive | | | | | | | 2 | 0.20% |
3 | replacement parts for ctmri | | | | | | | 2 | 0.20% |
4 | sleep and respiratory solution | | | | | | | 2 | 0.20% |
5 | equal and inclusive community | | | | | | | 2 | 0.20% |
6 | an empowered equal and | | | | | | | 2 | 0.20% |
7 | work towards an empowered | | | | | | | 1 | 0.10% |
8 | medical imaging products and | | | | | | | 1 | 0.10% |
9 | to a worldclass modern | | | | | | | 1 | 0.10% |
10 | a worldclass modern enterprise | | | | | | | 1 | 0.10% |
11 | kampo medical a trustworthy | | | | | | | 1 | 0.10% |
12 | medical a trustworthy largescale | | | | | | | 1 | 0.10% |
13 | a trustworthy largescale medical | | | | | | | 1 | 0.10% |
14 | trustworthy largescale medical imaging | | | | | | | 1 | 0.10% |
15 | largescale medical imaging products | | | | | | | 1 | 0.10% |
16 | business scope mri systems | | | | | | | 1 | 0.10% |
17 | in performance to work | | | | | | | 1 | 0.10% |
18 | scope mri systems xray | | | | | | | 1 | 0.10% |
19 | mri systems xray systems | | | | | | | 1 | 0.10% |
20 | systems xray systems related | | | | | | | 1 | 0.10% |
21 | xray systems related imaging | | | | | | | 1 | 0.10% |
22 | systems related imaging processing | | | | | | | 1 | 0.10% |
23 | softwares system upgrade solutions | | | | | | | 1 | 0.10% |
24 | system upgrade solutions and | | | | | | | 1 | 0.10% |
25 | upgrade solutions and services | | | | | | | 1 | 0.10% |
26 | solutions and services etc | | | | | | | 1 | 0.10% |
27 | contec to a worldclass | | | | | | | 1 | 0.10% |
28 | predominant in performance to | | | | | | | 1 | 0.10% |
29 | tech park covering 70000 | | | | | | | 1 | 0.10% |
30 | product hightech products with | | | | | | | 1 | 0.10% |
31 | of the international market | | | | | | | 1 | 0.10% |
32 | the international market informative | | | | | | | 1 | 0.10% |
33 | management diversifiable product we | | | | | | | 1 | 0.10% |
34 | diversifiable product we also | | | | | | | 1 | 0.10% |
35 | product we also dedicate | | | | | | | 1 | 0.10% |
36 | we also dedicate to | | | | | | | 1 | 0.10% |
37 | also dedicate to research | | | | | | | 1 | 0.10% |
38 | dedicate to research and | | | | | | | 1 | 0.10% |
39 | hightech products with more | | | | | | | 1 | 0.10% |
40 | more predominant in performance | | | | | | | 1 | 0.10% |